BROWSE·page 434 of 645

Browse EX-10 agreements

7,732 total material contract exhibits.


EX-10.1

Orthofix Medical Inc.

AMENDMENT NO. 5 TO

ORTHOFIX MEDICAL INC.

SECOND AMENDED AND RESTATED STOCK PURCHASE PLAN

The Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan (as amended to date, the “Plan”) is hereby amended as follows:

Section 3(a) of the Plan is amended and restated in its entirety to read in full as follows:

“The total number of shares of Orthofix Stock reserved and available for issuance pursuant to the Plan shall not exceed 6,100,000 shares. The shares of Orthofix Stock purchasable pursuant to the Plan may be authorized but previously unissued shares of Orthofix Stock or shares of Orthofix Stock held in treasury or purchased in the open market or in privately negotiated transactions. The Company shall bear all costs in connection with issuance or transfer of any shares and all commissions, fees and other charges incurred in purchasing shares for distribution pursuant to the Plan.”

 


EX-10.1·8-K·CIK 884624·ACC 0001193125-26-266679·Filed Jun 11, 2026, 07:01 ET

FORM OF DIRECTOR'S AGREEMENT

BILI Social International, Inc.

DIRECTOR AGREEMENT

 

This DIRECTOR AGREEMENT is made as of [·] [·], 202[·] (the “Agreement”), by and between BILI Social International, Inc. fka Allied Energy, Inc., a Florida corporation (the “Company”), and [·], an individual with an address of [·] (the “Director”).

 

WHEREAS, the Director was appointed to serve as a member of the Board of Directors of the Company (the “Board”) on [·] [·], 20[·], and the Company desires to enter into an agreement with the Director with respect to their service as a member of the Board; and

 

WHEREAS, the Director is willing to serve the Company on the terms set forth herein and in accordance with the provisions of this Agreement.

 

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:

EX-10.1·8-K·CIK 1109262·ACC 0001683168-26-004722·Filed Jun 11, 2026, 07:00 ET

EX-10.2

Kardigan, Inc.

KARDIGAN, INC.

2026 STOCK OPTION AND INCENTIVE PLAN

SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS

The name of the plan is the Kardigan, Inc. 2026 Stock Option and Incentive Plan (as amended from time to time, the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, Non-Employee Directors and Consultants of Kardigan, Inc. (the “Company”) and its Affiliates upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake in the Company’s welfare will assure a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their efforts on the Company’s behalf and strengthening their desire to remain with the Company or one of its Affiliates.

The following terms shall be defined as set forth below:

“Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations thereunder.

EX-10.2·S-1/A·CIK 2123613·ACC 0001193125-26-266629·Filed Jun 11, 2026, 06:16 ET

EX-10.3

Kardigan, Inc.

KARDIGAN, INC.

2026 EMPLOYEE STOCK PURCHASE PLAN

The purpose of the Kardigan, Inc. 2026 Employee Stock Purchase Plan (the “Plan”) is to provide eligible employees of Kardigan, Inc. (the “Company”) and each Designated Company (as defined in Section 11) with opportunities to purchase shares of the Company’s voting common stock, par value $0.00001 per share (the “Common Stock”). 1,180,000 shares of Common Stock in the aggregate have been approved and reserved for this purpose, plus on January 1, 2027 and each January 1 thereafter until the Plan terminates pursuant to Section 20, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) 2,360,000 shares of Common Stock, (ii) 1% of the number of Outstanding Shares on the immediately preceding December 31, and (iii) such lesser number of shares of Common Stock as determined by the Administrator (as defined in Section 1). The Plan includes two components: a Code Section 423 Component (the “423 Component”) and a non-Code Section 423 Component (the “No

EX-10.3·S-1/A·CIK 2123613·ACC 0001193125-26-266629·Filed Jun 11, 2026, 06:16 ET

EXHIBIT 10.15

Black Hawk Acquisition Corp

THIS CONVERTIBLE NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

CONVERTIBLE NOTE

 

Principal Amount: Up to $300,000

 

Dated as of May 4, 2026

EX-10.15·S-4/A·CIK 2000775·ACC 0001829126-26-006338·Filed Jun 11, 2026, 06:01 ET

EXHIBIT 10.1

Copley Acquisition Corp

SELLER SUPPORT AGREEMENT

 

This Seller Support Agreement (this “Agreement”) is made as of June 10, 2026 by and among (i) Copley Acquisition Corp, a Cayman Islands exempted company incorporated with limited liability (together with its successors, including after the Conversion (as defined below), the “SPAC”), (ii) Ignite Proteomics, LLC, a Delaware limited liability company (the “Company”), and (iii) the undersigned holders of membership interests and/or interests convertible into membership interests (collectively, the “Holders” and each, a “Holder”) of the Company. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Business Combination Agreement.

EX-10.1·8-K·CIK 2045473·ACC 0001829126-26-006336·Filed Jun 11, 2026, 06:00 ET

EXHIBIT 10.3

Copley Acquisition Corp

SIDE LETTER AND GUARANTY AGREEMENT

 

This Side Letter and Guaranty Agreement (this “Guaranty”) is made and entered into as of June 10, 2026, by and between Aditxt Inc., a Delaware corporation (“Guarantor”), and Copley Acquisition Corp, an exempted company incorporated under the laws of the Cayman Islands (“SPAC”).

 

RECITALS

 

WHEREAS, SPAC, Ignite Proteomics Holdings, Inc., a Delaware corporation (“Pubco”), Ignite Merger Sub I Inc., a Delaware corporation, Ignite Merger Sub II LLC, a Delaware limited liability company, Jeffrey M. Busch, as Seller Representative, Chibo Tang, as SPAC Representative, and Ignite Proteomics, LLC, a Delaware limited liability company (the “Company”), have entered into that certain Business Combination Agreement, dated as of June 10, 2026 (as may be amended, restated, supplemented or otherwise modified from time to time, the “Business Combination Agreement”);

WHEREAS, the Company is a direct subsidiary of Guarantor;

EX-10.3·8-K·CIK 2045473·ACC 0001829126-26-006336·Filed Jun 11, 2026, 06:00 ET

EXHIBIT 10.2

Copley Acquisition Corp

AMENDMENT TO LETTER AGREEMENT

THIS AMENDMENT TO LETTER AGREEMENT (this “Amendment”) is made and entered into as of June 10, 2026, and shall be effective as of the Closing (defined below), by and among (i) Copley Acquisition Corp, a Cayman Islands exempted company incorporated with limited liability (“Company” or the “SPAC”), (ii) Copley Acquisition Sponsors, LLC, a Delaware limited liability company (the “Sponsor”), (iii) Ignite Proteomics Holdings, Inc., a Delaware corporation (“Pubco”), (iv) Ignite Proteomics, LLC, a Delaware limited liability company (the “Target Company”), and (v) the undersigned individuals, each of whom is a member of the Company’s board of directors and/or management team and who, along with the Sponsor and other transferees of the applicable Company securities, is referred to as an “Insider” pursuant to the terms of the Letter Agreement (as defined below). Capitalized terms used but not otherwise defined herein shall have the respective meanings assigned to such terms in the Original Letter Ag

EX-10.2·8-K·CIK 2045473·ACC 0001829126-26-006336·Filed Jun 11, 2026, 06:00 ET

EX-10.1

TILLY'S, INC.

Document

TILLY’S, INC. FOURTH AMENDED AND RESTATED 2012 EQUITY AND INCENTIVE AWARD PLAN

Article 1.

PURPOSE

The purpose of the Tilly’s, Inc. Fourth Amended and Restated 2012 Equity and Incentive Award Plan (as it may be amended or restated from time to time, the “Plan”) is to promote the success and enhance the value of Tilly’s, Inc. (the “Company”) by linking the individual interests of the members of the Board, Employees, and Consultants to those of Company stockholders and by providing such individuals with an incentive for outstanding performance to generate superior returns to Company stockholders. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract, and retain the services of members of the Board, Employees, and Consultants upon whose judgment, interest, and special effort the successful conduct of the Company’s operation is largely dependent. The Plan amends and restates in its entirety the Tilly’s, Inc. Third Amended and Restated 2012 Equity and Incentive Award Plan (the “Original Plan”).

Article 2.

EX-10.1·8-K·CIK 1524025·ACC 0001628280-26-042353·Filed Jun 10, 2026, 21:41 ET

EX-10.1

PureCycle Technologies, Inc.

EXECUTION VERSION

LIMITED CONSENT AND ELEVENTH AMENDMENT TO CREDIT AGREEMENT

This LIMITED CONSENT AND ELEVENTH AMENDMENT TO CREDIT AGREEMENT, dated as of June 10, 2026 (this “Amendment”), is entered into by and among (a) PURECYCLE TECHNOLOGIES, INC., a Delaware corporation (the “Borrower”), (b) PURECYCLE TECHNOLOGIES HOLDINGS CORP., a Delaware Corporation (“Holdings”), (c) PURECYCLE TECHNOLOGIES, LLC, a Delaware limited liability company (“PureCycle LLC”), (d) PURECYCLE AUGUSTA, LLC, a Delaware limited liability company (“PureCycle Augusta”), (e) PURECYCLE (THAILAND) COMPANY LIMITED, a Thai limited liability company (“PureCycle Thailand” and, together with Holdings, PureCycle LLC and PureCycle Augusta, collectively, the “Guarantors”), (f) KROLL TRUSTEE SERVICES (HK) LIMITED, as Administrative Agent (in such capacity, the “Administrative Agent”), and (g) KROLL TRUSTEE SERVICES (HK) LIMITED, as Security Agent (in such capacity, the “Security Agent”).

PRELIMINARY STATEMENTS:

EX-10.1·8-K·CIK 1830033·ACC 0001193125-26-266413·Filed Jun 10, 2026, 21:27 ET

EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”) is made as of May 28, 2026 (the “Effective Date”), by and between Olenox Industries Inc., a Delaware corporation (the “Company”), and Erik Blum, an individual residing at                                   .

RECITALS

 

WHEREAS, the Company desires to employ Executive in the position of President, and Executive desires to be employed by the Company, pursuant to the terms and conditions hereof;

 

NOW THEREFORE, in consideration of the premises and of the mutual promises herein contained, the parties hereto agree as follows:

 

1. EMPLOYMENT. The Company hereby employs Executive and Executive hereby agrees to be employed by the Company, subject to the terms and conditions hereinafter set forth.

EX-10.1·8-K·CIK 1023994·ACC 0001213900-26-067507·Filed Jun 10, 2026, 21:15 ET

EX-10.1

KIORA PHARMACEUTICALS INC

Document

KIORA PHARMACEUTICALS, INC.

2024 Equity Incentive Plan

(As Amended on June 10, 2026)

ARTICLE 1. INTRODUCTION

The Plan was adopted by the Board on March 14, 2024, and will become effective immediately upon its approval by the Company’s stockholders. The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by (a) encouraging Service Providers to focus on critical long-range corporate objectives, (b) encouraging the attraction and retention of Service Providers with exceptional qualifications and (c) linking Service Providers directly to stockholder interests through increased stock ownership. The Plan seeks to achieve this purpose by providing for Awards in the form of Options (which may constitute ISOs or NSOs), SARs, Restricted Shares, Stock Units, Performance Cash Awards and Other Awards. Capitalized terms used in this Plan are defined in Article 14.

ARTICLE 2. ADMINISTRATION.

EX-10.1·8-K·CIK 1372514·ACC 0001372514-26-000059·Filed Jun 10, 2026, 18:39 ET